Cargando…
Elevated Vacuolar Uptake of Fluorescently Labeled Antifungal Drug Caspofungin Predicts Echinocandin Resistance in Pathogenic Yeast
[Image: see text] Echinocandins are the newest class of antifungal drugs in clinical use. These agents inhibit β-glucan synthase, which catalyzes the synthesis of β-glucan, an essential component of the fungal cell wall, and have a high clinical efficacy and low toxicity. Echinocandin resistance is...
Autores principales: | Jaber, Qais Z., Bibi, Maayan, Ksiezopolska, Ewa, Gabaldon, Toni, Berman, Judith, Fridman, Micha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596861/ https://www.ncbi.nlm.nih.gov/pubmed/33145409 http://dx.doi.org/10.1021/acscentsci.0c00813 |
Ejemplares similares
-
Benzylic
Dehydroxylation of Echinocandin Antifungal
Drugs Restores Efficacy against Resistance Conferred by Mutated Glucan
Synthase
por: Logviniuk, Dana, et al.
Publicado: (2022) -
Echinocandins Localized to the Target-Harboring Cell
Surface Are Not Degraded but Those Entering the Vacuole Are
por: Jaber, Qais Z., et al.
Publicado: (2022) -
Comparison of echinocandin antifungals
por: Eschenauer, Gregory, et al.
Publicado: (2007) -
Combining Colistin and Fluconazole Synergistically
Increases Fungal Membrane Permeability and Antifungal Cidality
por: Bibi, Maayan, et al.
Publicado: (2021) -
Echinocandin-Induced Microevolution of Candida parapsilosis Influences Virulence and Abiotic Stress Tolerance
por: Papp, Csaba, et al.
Publicado: (2018)